ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe

ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe. A Bayle,J Bonastre,D Chaltiel,et al. . 2023; :

Consulter

• Oncostat

Article